Navigation Links
New test announced for major killer of lung transplant patients
Date:12/30/2010

ANN ARBOR, Mich. A lung transplant can mean a new chance at life. But many who receive one develop a debilitating, fatal condition that causes scar tissue to build up in the lungs and chokes off the ability to breathe.

University of Michigan researchers hope a new diagnostic tool they developed to predict bronchiolitis obliterans syndrome (BOS) will allow doctors to intervene earlier and, ultimately, to provide life-saving treatments.

BOS is the leading cause of death for those who survive one year after lung transplantation and more than half of recipients will develop BOS within five years. There is currently no cure.

Vibha Lama, M.D., M.S., an assistant professor of pulmonary and critical care medicine at the University of Michigan Medical School, led a team of U-M researchers who recently discovered that patients who had a high number of stem cells in their lungs six months after transplantation were much more likely to develop BOS than those with lower counts.

"Our study provides the first indication of the important role these cells play in both human repair and disease," Lama says. "It's very important from the clinical perspective because we didn't previously have any strong biomarkers for BOS."

The findings were recently published online ahead of print publication in the American Journal of Respiratory and Critical Care Medicine.

The translational study also highlights the importance of the lab-to-bedside cooperation of basic and clinical research, Lama says.

While the exact relationship between the mesenchymal stromal cells and BOS remains unclear, doctors know that most of the cells originate with the donor and not the recipient. Spikes in cell counts are seen shortly after transplantation as the body responds to the injury; those levels usually taper off, but a second rise of cell counts after about six months is linked to a patient's likelihood of developing BOS.

In 2007, Lama and her colleagues published another discovery about the stem cells, revealing that the cells reside in the transplanted organs, independent of their more commonly known association with bone marrow. That study led to the further exploration of the cells' involvement with chronic transplant rejection.

The new findings also have the potential to spur research that will help people suffering from other types of lung disease, such as idiopathic pulmonary fibrosis, known as IPF.

Having the biomarker will also allow researchers to readily identify a population of patients ideal for testing new drug interventions and therapies.

"By the time we usually diagnose BOS, there's already been a huge decline in lung function," Lama says. "If we can find the disease early, we can potentially do something about it."


'/>"/>

Contact: Ian Demsky
idemsky@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related medicine news :

1. Autism Consortium 2010 Symposium: New therapeutics focus, family resource guide announced
2. Popular Mechanics breakthrough awardees announced
3. MARC Travel Awards announced for the 2010 Integrative Physiology of Exercise Meeting
4. Significant advance announced in treatment of cervical cancer
5. Civil society and local partners for XIX International AIDS Conference (AIDS 2012) announced
6. State of the Art Hospital for Rural Kenya Announced by California Foundation
7. New Health Reform Law Claim Denial Appeal Book Announced for Healthcare Providers to Comply with New PPACA Deadline - 09/23/2010
8. KFx Medical Corporation Announced Today It Has Received FDA 510k Clearance for Product(s) Used in a Wide Variety of Knee Procedures
9. 2010 OTC National Advertising Award Winners Announced
10. Lumenis Announced Today it is Sponsoring the Endometriosis Foundation of America's Symposium 'Advancing the Art and Science of Endometriosis: Stem Cells to Radical Excision Surgery'
11. SIUE Pain Summit Recommendations Announced Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... For many artists, the act of blending paint ... it into a science. , Using the new, highly precise METTLER TOLEDO ML204T ... add depth and meaning to his works. What’s more, it has allowed him to ...
(Date:5/2/2016)... ... May 02, 2016 , ... The debilitating disease of arthritis can bring patients ... most patients must deal with prescription costs to treat arthritis over the course of ... savings at the pharmacy on many common prescriptions. , Arthritis , Although arthritis is ...
(Date:5/2/2016)... ... May 02, 2016 , ... Summit BHC (Summit), a ... of Twin Lakes Recovery Center. Located east of Atlanta in Monroe, Georgia, ... The residential facility is set on 34 acres of beautiful, secluded property that ...
(Date:5/2/2016)... ... May 02, 2016 , ... Marshall Votta, Josh Holmes and Laura ... development roles to drive RowdMap Inc.’s market growth across both health plans and provider ... order to succeed in value based care. , Marshall Votta joins RowdMap, Inc. as ...
(Date:5/1/2016)... , ... May 02, 2016 , ... ... for original 1968 Jimi Hendrix Merriweather Post Pavilion in Columbia, Maryland concert posters. ... concert poster. The concert was held on August 16. According to Hawley, “The ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... of oral drug delivery systems, announced today that the Company ... Joseph Gunnar & Co. LLC, taking place on ... Nadav Kidron , CEO of Oramed, will present a ...   PIONEERS 2016, presented by Joseph Gunnar ...
Breaking Medicine Technology: